Tango Therapeutics (TNGX) Stock Insights

TNGX price $22.63 -0.26 -1.15%

Ticker
TNGX
Price
$22.63
Change
-0.26 -1.15%
Market cap ?
$3.82B
P/E ?
-26.75
Forward P/E ?
18.33
Dividend yield ?
0.00%
Beta ?
1.17
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
45
Quality
47
Growth
100

Stocklytics score rationale: value 45, quality 47, growth 100.

Financials

2019202020212022202320242025
2464900076560003704200024860000365270004206900062384000

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions…

Fair value

TNGX fair value $24.78. Price $22.63. Price is 9% below fair value.

Above fair value, and more expensive than usual. A larger premium than on 92% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 10.91M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.73% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 168.61M. Net debt -78.71M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare TNGX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.35—3.28M
2026-08-10-0.37-0.32—1.56M
2026-05-13-0.32-0.31—578.09K
2026-03-05-0.29-0.31—500.40K
2025-11-040.130.0153.81M556.00K
2025-08-05-0.35-0.353.18M6.41M
2025-05-12-0.36-0.345.39M6.36M
2025-02-27-0.35-0.324.12M8.02M
2024-11-06-0.27-0.3411.61M8.02M
2024-08-07-0.24-0.3419.88M7.42M
2024-05-08-0.35-0.316.47M6.67M
2024-03-18-0.32-0.285.43M8.24M
2023-11-08-0.23-0.3410.73M8.62M
2023-08-07-0.23-0.3514.60M7.58M
2023-05-09-0.32-0.365.77M6.71M
2023-03-27-0.33-0.366.41M6.44M
2022-11-10-0.33-0.326.92M5.64M
2022-08-10-0.28-0.335.77M5.66M
2022-05-11-0.29-0.285.76M5.83M
2022-03-28-0.25-0.285.72M6.57M
2021-11-09-0.28-0.286.79M6.26M
2021-08-06-0.05—18.15M—
2021-07-17-0.14—6.39M—
2021-03-31-0.42—9.14M—
2020-11-13-0.31—11.26M—
2020-06-30-0.75—5.06M—
2020-03-31-0.74—4.71M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Crystal AdamSell27.00K$5.20140.40K
2026-10-01Crystal AdamBuy27.00K$5.20140.40K
2026-10-01Crystal AdamSell26.40K$24.45645.60K
2026-10-01Crystal AdamSell600$25.3215.19K
2026-09-22Newcomb JessicaSell700$22.8015.96K
2026-09-22Newcomb JessicaSell5.10K$23.97122.24K
2026-09-22Newcomb JessicaSell2.40K$25.1760.41K
2026-09-01Crystal AdamSell27.00K$5.20140.40K
2026-09-01Crystal AdamBuy27.00K$5.20140.40K
2026-09-01Crystal AdamSell27.00K$22.37603.91K
2026-08-03Crystal AdamSell27.00K$5.20140.40K
2026-08-03Crystal AdamBuy27.00K$5.20140.40K
2026-08-03Crystal AdamSell5.27K$26.79141.10K
2026-08-03Crystal AdamSell21.73K$27.35594.42K
2026-07-01Crystal AdamSell27.00K$5.20140.40K
2026-07-01Crystal AdamBuy27.00K$5.20140.40K
2026-07-01Crystal AdamSell19.63K$29.34575.96K
2026-07-01Crystal AdamSell7.37K$30.25222.95K
2026-06-19Azelby RobertBuy35.91K$27.971.00M
2026-06-19Azelby RobertBuy5.74K——
2026-06-19Azelby RobertOther0——
2026-06-05Ketchum John BBuy25.00K$20.22505.50K
2026-06-05Ketchum John BBuy4.00K——
2026-06-05Calhoun Lesley AnnBuy25.00K$20.22505.50K
2026-06-05Calhoun Lesley AnnBuy4.00K——
2026-06-05Rothenberg MaceBuy4.00K——
2026-06-05Rothenberg MaceBuy25.00K$20.22505.50K
2026-06-05Lee SungBuy570——
2026-06-05Lee SungBuy3.57K$20.2272.19K
2026-06-01Crystal AdamSell27.00K$5.20140.40K
2026-06-01Crystal AdamBuy27.00K$5.20140.40K
2026-06-01Crystal AdamSell6.14K$22.25136.63K
2026-06-01Crystal AdamSell20.86K$23.06480.94K
2026-05-01Crystal AdamSell27.00K$5.20140.40K
2026-05-01Crystal AdamBuy27.00K$5.20140.40K
2026-05-01Crystal AdamSell25.90K$21.19548.90K
2026-05-01Crystal AdamSell1.10K$22.0024.20K
2026-05-01Gall MatthewBuy240.00K$20.985.04M
2026-05-01Gall MatthewBuy40.00K——
2026-04-29Lee SungBuy12.30K——
2026-04-29Lee SungBuy5.20K$22.06114.71K
2026-04-15Newcomb JessicaOther0——
2026-04-15Newcomb JessicaOther153.09K$11.941.83M
2026-04-15Newcomb JessicaOther130.00K$4.26553.80K
2026-04-15Newcomb JessicaOther31.42K$5.20163.37K
2026-04-15Newcomb JessicaOther2.00K$2.675.34K
2026-04-15Newcomb JessicaOther74.30K$12.28912.34K
2026-04-15Newcomb JessicaOther10.00K$3.1331.30K
2026-04-15Newcomb JessicaOther126.19K$2.91367.21K
2026-04-15Newcomb JessicaOther1.00K$8.938.93K
2026-04-15Gall MatthewOther0——
2026-04-15Crystal AdamSell38.46K$5.20199.99K
2026-04-15Crystal AdamBuy38.46K$5.20199.99K
2026-04-15Crystal AdamSell38.46K$25.00961.50K
2026-04-01Crystal AdamSell27.00K$5.20140.40K
2026-04-01Crystal AdamBuy27.00K$5.20140.40K
2026-04-01Crystal AdamSell27.00K$21.20572.48K
2026-03-25Crystal AdamSell12.00K$5.2062.40K
2026-03-25Crystal AdamBuy12.00K$5.2062.40K
2026-03-25Crystal AdamSell12.00K$20.11241.32K
2026-03-05Crystal AdamSell20.25K$15.00303.76K
2026-02-25Crystal AdamSell54.34K$12.77694.21K
2026-02-03Beckman DaniellaSell10.20K$12.26125.07K
2026-02-03Beckman DaniellaSell113$12.901.46K
2026-02-03Weber BarbaraSell30.19K$12.26370.00K
2026-02-03Weber BarbaraSell333$12.904.29K
2026-02-03Crystal AdamSell18.25K$12.26223.71K
2026-02-03Crystal AdamSell201$12.902.59K
2026-02-02Beckman DaniellaBuy265.98K$11.943.18M
2026-02-02Beckman DaniellaBuy44.33K——
2026-02-02Weber BarbaraBuy37.52K——
2026-02-02Weber BarbaraBuy222.13K$11.942.65M
2026-02-02Crystal AdamBuy284.76K$11.943.40M
2026-02-02Crystal AdamBuy47.46K——
2026-01-08Peters MalteBuy1.65M$11.0618.25M
2026-01-08Peters MalteBuy350.00K——
2026-01-02Lee SungBuy60.00K$8.93535.80K
2026-01-02Lee SungBuy10.00K——
2026-01-02Lee SungOther0——
2025-11-03Peters MalteBuy150.00K$8.011.20M
2025-10-23Third Rock Ventures IV, L.P.Sell477.40K$10.154.85M
2025-09-25Third Rock Ventures IV, L.P.Sell500.00K$8.024.01M
2025-09-16Third Rock Ventures IV, L.P.Sell363.54K$7.042.56M
2025-09-08Third Rock Ventures IV, L.P.Sell86.46K$7.04608.63K
2025-09-05Third Rock Ventures IV, L.P.Sell642.91K$7.004.50M
2025-08-22Third Rock Ventures IV, L.P.Sell302.19K$7.002.12M
2025-08-19Third Rock Ventures IV, L.P.Sell1.10M$7.017.71M
2025-06-05Peters MalteBuy37.50K$3.51131.62K
2025-06-05Peters MalteBuy6.25K——
2025-06-05Calhoun Lesley AnnBuy37.50K$3.51131.62K
2025-06-05Calhoun Lesley AnnBuy6.25K——
2025-06-05Rothenberg MaceBuy37.50K$3.51131.62K
2025-06-05Rothenberg MaceBuy6.25K——
2025-06-05Ketchum John BBuy37.50K$3.51131.62K
2025-06-05Ketchum John BBuy6.25K——
2025-06-05Borisy AlexisBuy37.50K$3.51131.62K
2025-06-05Borisy AlexisBuy6.25K——
2025-02-05Barry DouglasSell2.56K$3.168.08K
2025-02-05Beckman DaniellaSell3.95K$3.1612.48K
2025-02-05Crystal AdamSell6.85K$3.1621.66K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 259, holders +61 vs prior quarter. Ownership 143.40%.

HolderSharesChangeChange %Value
RTW INVESTMENTS, LP13.90M600.00K+4.51%434.53M
BLACKROCK, INC.12.44M3.69M+42.19%388.83M
FMR LLC12.33M2.43M+24.50%385.54M
FARALLON CAPITAL MANAGEMENT, L.L.C.12.28M3.18M+34.95%383.78M
BOXER CAPITAL MANAGEMENT, LLC10.88M00.00%339.99M
GOLDMAN SACHS GROUP INC9.98M4.90M+96.61%311.99M
TCG CROSSOVER MANAGEMENT, LLC9.08M-1.45M-13.77%283.88M
PARADIGM BIOCAPITAL ADVISORS LP6.36M2.35M+58.55%198.74M
PRICE T ROWE ASSOCIATES INC /MD/6.35M5.46M+613.83%198.47M
SIREN, L.L.C.6.18M522.26K+9.23%193.17M
STATE STREET CORP5.98M1.33M+28.55%186.93M
VANGUARD CAPITAL MANAGEMENT LLC5.96M795.92K+15.42%186.23M
ADAGE CAPITAL PARTNERS GP, L.L.C.5.60M-7.21M-56.28%175.06M
JUPITER TOPCO LLC5.06M5.06MNew157.99M
DEEP TRACK CAPITAL, LP4.20M1.45M+52.73%131.29M
DEERFIELD MANAGEMENT COMPANY, L.P.4.19M43.80K+1.06%131.00M
WOODLINE PARTNERS LP4.00M-4.00M-49.99%125.06M
TRV GP IV, LLC6.37M00.00%120.18M
GEODE CAPITAL MANAGEMENT, LLC3.74M1.07M+39.88%117.02M
PERCEPTIVE ADVISORS LLC3.38M2.57M+317.87%105.57M
SEVEN FLEET CAPITAL MANAGEMENT LP3.23M2.73M+543.04%95.66M
LOGOS GLOBAL MANAGEMENT LP2.85M-150.00K-5.00%89.09M
CALIGAN PARTNERS LP2.50M91.31K+3.79%78.15M
HOLOCENE ADVISORS, LP2.41M-1.52M-38.69%75.37M
COMMODORE CAPITAL LP2.25M2.25MNew70.33M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Tango Therapeutics (TNGX) Stock Insights

TNGX$22.63-0.26 -1.15%

$3.82B

Market Cap

-26.75

P/E

18.33

Forward P/E

64

Score

Price History